(MHO) M/I Homes - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US55305B1017
MHO EPS (Earnings per Share)
MHO Revenue
MHO: Single-Family Homes, Townhomes, Land Development, Mortgages
M/I Homes Inc (NYSE:MHO) is a leading homebuilder operating in nine states across the US, with a diverse portfolio catering to various demographics, including first-time buyers, millennials, and luxury homebuyers. The companys business is segmented into Northern Homebuilding, Southern Homebuilding, and Financial Services, allowing for a nuanced approach to different markets and customer needs.
The companys operational strategy involves designing, constructing, and marketing single-family homes and attached townhomes, as well as purchasing undeveloped land for development into lots for its own construction projects or for sale to other builders. Additionally, M/I Homes provides financial services, including mortgage origination and title insurance, enhancing its customer offering and revenue streams.
With a history dating back to 1976, M/I Homes has established itself as a reputable brand in the homebuilding industry. Its presence in Ohio, Indiana, Illinois, Minnesota, Michigan, Florida, Texas, North Carolina, and Tennessee positions it well for growth in various regional markets. The companys commitment to serving a broad customer base, from first-time buyers to luxury homebuyers, is a key aspect of its business model.
Analyzing the
Forecasting MHOs future performance, we can consider the combination of its technical and fundamental data. If the stock continues to stabilize above its SMA20 and SMA50, and given its relatively low P/E ratio, theres potential for a rebound. However, the ongoing downtrend indicated by the SMA200 and the current market conditions will be crucial in determining the stocks direction. A potential target could be a return to its 52-week high, around $174.92, although this would depend on significant improvements in market sentiment and the companys financial performance. For now, a cautious approach, closely monitoring the stocks price action and fundamental developments, would be prudent.
Additional Sources for MHO Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
MHO Stock Overview
Market Cap in USD | 2,892m |
Sector | Consumer Cyclical |
Industry | Residential Construction |
GiC Sub-Industry | Homebuilding |
IPO / Inception | 1986-10-03 |
MHO Stock Ratings
Growth Rating | 48.6 |
Fundamental | 55.6 |
Dividend Rating | 8.43 |
Rel. Strength | -4.94 |
Analysts | 5 of 5 |
Fair Price Momentum | 117.29 USD |
Fair Price DCF | 95.61 USD |
MHO Dividends
Currently no dividends paidMHO Growth Ratios
Growth Correlation 3m | -26.9% |
Growth Correlation 12m | -73.9% |
Growth Correlation 5y | 78.6% |
CAGR 5y | 28.27% |
CAGR/Max DD 5y | 0.55 |
Sharpe Ratio 12m | 0.71 |
Alpha | -17.91 |
Beta | 0.723 |
Volatility | 39.59% |
Current Volume | 281.1k |
Average Volume 20d | 203.3k |
As of June 24, 2025, the stock is trading at USD 110.37 with a total of 281,078 shares traded.
Over the past week, the price has changed by +2.21%, over one month by +3.78%, over three months by -8.35% and over the past year by -10.36%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, M/I Homes (NYSE:MHO) is currently (June 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 55.59 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MHO is around 117.29 USD . This means that MHO is currently overvalued and has a potential downside of 6.27%.
M/I Homes has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy MHO.
- Strong Buy: 3
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, MHO M/I Homes will be worth about 128.2 in June 2026. The stock is currently trading at 110.37. This means that the stock has a potential upside of +16.16%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 158.7 | 43.8% |
Analysts Target Price | 158.7 | 43.8% |
ValueRay Target Price | 128.2 | 16.2% |